207 related articles for article (PubMed ID: 27028221)
21. Atherogenic index of plasma in non-obese women with androgenetic alopecia.
Bakry OA; El Farargy SM; Ghanayem N; Soliman A
Int J Dermatol; 2015 Sep; 54(9):e339-44. PubMed ID: 26096895
[TBL] [Abstract][Full Text] [Related]
22. Association of Early-onset Androgenetic Alopecia and Metabolic Syndrome.
Sheikh FZ; Butt G; Hafeez R; Maqsood A; Altaf F; Hussain I
J Coll Physicians Surg Pak; 2021 Feb; 31(2):123-127. PubMed ID: 33645175
[TBL] [Abstract][Full Text] [Related]
23. Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship?
Agamia NF; Abou Youssif T; El-Hadidy A; El-Abd A
Arab J Urol; 2016 Jun; 14(2):157-62. PubMed ID: 27489744
[TBL] [Abstract][Full Text] [Related]
24. A study on relationship between androgenetic alopecia and cardiovascular risk using high sensitivity C-reactive protein and galectin-3 in men with early onset baldness.
Sözen M; Baldane S; Abusoglu S; Kebapcılar L; Kebapcılar A; Tunçez Akyürek F; Ünlü A; İpekci SH
Biomarkers; 2022 Feb; 27(1):71-78. PubMed ID: 34852684
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for male lower urinary tract symptoms: the role of metabolic syndrome and androgenetic alopecia in a Latin American population.
Barbosa JA; Muracca E; Nakano E; Paranhos M; Natalino R; Cordeiro P; Srougi M; Antunes AA
Urology; 2013 Jul; 82(1):182-8. PubMed ID: 23642850
[TBL] [Abstract][Full Text] [Related]
26. Frequency, severity and related factors of androgenetic alopecia in dermatology outpatient clinic: hospital-based cross-sectional study in Turkey.
Salman KE; Altunay IK; Kucukunal NA; Cerman AA
An Bras Dermatol; 2017; 92(1):35-40. PubMed ID: 28225954
[TBL] [Abstract][Full Text] [Related]
27. Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study.
Bakry OA; Shoeib MA; El Shafiee MK; Hassan A
Indian Dermatol Online J; 2014 Jul; 5(3):276-81. PubMed ID: 25165643
[TBL] [Abstract][Full Text] [Related]
28. Patients with a large prostate show a higher prevalence of androgenetic alopecia.
Chen W; Yang CC; Chen GY; Wu MC; Sheu HM; Tzai TS
Arch Dermatol Res; 2004 Nov; 296(6):245-9. PubMed ID: 15517324
[TBL] [Abstract][Full Text] [Related]
29. Association of early-onset androgenetic alopecia and metabolic syndrome in Thai men: a case-control study.
Pengsalae N; Tanglertsampan C; Phichawong T; Lee S
J Med Assoc Thai; 2013 Aug; 96(8):947-51. PubMed ID: 23991602
[TBL] [Abstract][Full Text] [Related]
30. The combination of overweight and smoking increases the severity of androgenetic alopecia.
Fortes C; Mastroeni S; Mannooranparampil TJ; Ribuffo M
Int J Dermatol; 2017 Aug; 56(8):862-867. PubMed ID: 28555720
[TBL] [Abstract][Full Text] [Related]
31. Association of androgenetic alopecia with mortality from diabetes mellitus and heart disease.
Su LH; Chen LS; Lin SC; Chen HH
JAMA Dermatol; 2013 May; 149(5):601-6. PubMed ID: 23677087
[TBL] [Abstract][Full Text] [Related]
32. Long-term efficacy and safety of dutasteride 0.5 mg in Korean men with androgenetic alopecia: 5-year data demonstrating clinical improvement with sustained efficacy.
Choi S; Kwon SH; Sim WY; Lew BL
J Dermatol; 2024 May; 51(5):684-690. PubMed ID: 38321615
[TBL] [Abstract][Full Text] [Related]
33. Implications of cigarette smoking on early-onset androgenetic alopecia: A cross-sectional Study.
Salem AS; Ibrahim HS; Abdelaziz HH; Elsaie ML
J Cosmet Dermatol; 2021 Apr; 20(4):1318-1324. PubMed ID: 32946667
[TBL] [Abstract][Full Text] [Related]
34. Hyperuricemia is associated with androgenetic alopecia in men: A cross-sectional case-control study.
Ma J; Sheng Y; Lao Z; Zhao J; Yang Q
J Cosmet Dermatol; 2020 Nov; 19(11):3122-3126. PubMed ID: 32281237
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with early-onset androgenetic alopecia: A scoping review.
Liu LP; Wariboko MA; Hu X; Wang ZH; Wu Q; Li YM
PLoS One; 2024; 19(3):e0299212. PubMed ID: 38451966
[TBL] [Abstract][Full Text] [Related]
36. Hypertension and aldosterone levels in women with early-onset androgenetic alopecia.
Arias-Santiago S; Gutiérrez-Salmerón MT; Buendía-Eisman A; Girón-Prieto MS; Naranjo-Sintes R
Br J Dermatol; 2010 Apr; 162(4):786-9. PubMed ID: 19906217
[TBL] [Abstract][Full Text] [Related]
37. Health-related quality of life and physical well-being among a 63-year-old cohort of women with androgenetic alopecia; a Finnish population-based study.
Hirsso P; Rajala U; Laakso M; Hiltunen L; Härkönen P; Keinänen-Kiukaanniemi S
Health Qual Life Outcomes; 2005 Aug; 3():49. PubMed ID: 16120206
[TBL] [Abstract][Full Text] [Related]
38. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
39. [Male androgenetic alopecia and cardiovascular risk factors: A case-control study].
Arias-Santiago S; Gutiérrez-Salmerón MT; Castellote-Caballero L; Buendía-Eisman A; Naranjo-Sintes R
Actas Dermosifiliogr; 2010 Apr; 101(3):248-56. PubMed ID: 20398601
[TBL] [Abstract][Full Text] [Related]
40. Lipid profile in patients with androgenetic alopecia: a meta-analysis.
Kim MW; Shin IS; Yoon HS; Cho S; Park HS
J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):942-951. PubMed ID: 27717019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
